Twist Bioscience Corporation TWST Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's stock issuance proceeds?
- Twist Bioscience Corporation (TWST) reported stock issuance proceeds of $1.79M in Q1 2026.
- How has Twist Bioscience Corporation's stock issuance proceeds changed year-over-year?
- Twist Bioscience Corporation's stock issuance proceeds increased by 131.7% year-over-year, from $772K to $1.79M.
- What is the long-term trend for Twist Bioscience Corporation's stock issuance proceeds?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's stock issuance proceeds has grown at a -10.5% compound annual growth rate (CAGR), from $14.56M to $9.34M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.